Psea..— This what Daniel Davis a professor of

Psea..—

This what Daniel Davis a professor of Immunology at University of Manchester said about this news ..

“ At the moment , this is very basic research , and not close to actual medicine for patients “

They saying they will try to inject some terminal patients in November , we will see .

This research is similar to CAR-T treatment , but they injecting back to patients genetically modified T- cells .

I am interested to see results , but even more interested to see what side effects it may have in human ..

We know about severe side effects with CAR-T treatment , and possibilities of severe problems with gene therapy ..

With time we will see if this research will become a treatment ,
and then like CAR-T if it will be a treatment it might be mostly for patients without other options.



All IMO as always .